Skip to main content

Growing Economic Burden of Chronic Diseases Paving the Way for Precision Medicine Market

 

Rising economic burden of chronic diseases is considered to be one of the significant challenges that healthcare and biomedical research and development systems are facing at present. The high prevalence of chronic diseases, such as cancer, diabetes, cardiovascular diseases, and respiratory diseases, among others, is a prime concern across the globe. The chronic diseases have been responsible for 60% of the deaths worldwide and constitute approximately 43% of the global economic burden for diseases. According to World Health Organization in 2016, healthcare spending increased from 2.4% to 7.5% between 2015 and 2020.By 2020, the global spending on diseases, such as cardiovascular diseases, cancer, and respiratory diseases, is expected to reach $4 trillion. The chronic conditions hold approximately 65% of the annual healthcare cost of any country and one-third of the global population at present. Figure3: Chronic Conditions: Key Statistics Source: WHO Website, Deloitte 2016 Survey of U.S. Health Care Consumers, and BIS Research Analysis Chronic Conditions: Key Statistics1/3rdof the Global Population Approximately 65% of the country’s annual health care costs$4 Trillion Economic Loss Due to Chronic Conditions By 2020CancerCardiovascularMetabolic Conditions Others Precision Medicine Potential $200 Billion Savings from Chronic Conditions by 2025

 

The growth of the precision medicine market over the last few years have been monumental. The factors propelling the growth of the precision medicine market are increasing focus on targeted therapy by reducing trial-and-error medicine, growing demand for non-invasive testing procedures, reducing adverse  drug  reactions  through  pharmacogenomics  testing,  advancement  of  technology  in understanding human biology & disease susceptibility, and shift in the significance of medicine from reaction to prevention, among others. However, several clinical, economic, ethical, and regulatory conditions continue to challenge the growth of the market.

Labels:

Comments

Post a Comment

Popular posts from this blog

Personal Care Ingredients Market Size, Share & Trends Analysis Report 2019-2029

The introduction and proliferation of bio-based ingredients in several industries, such as food and beverage, pharmaceuticals, and cosmetics, has been transforming the manufacturing landscape since 2000. Growing consumer inclination toward the adoption of bio-based products due to rising health and environmental concerns is driving the demand for bio-based ingredients in the cosmetics and personal care products. Besides, awareness among consumers regarding the harmful effects of synthetic ingredients chemicals has grown rapidly over the past years. In addition, the availability of green raw materials has also urged large cosmetic firms to develop bio-based cosmetic products. However, limited availability of raw material, due to erratic weather conditions and stringent environmental regulations, can pose substantial hurdles in the production of bio-based ingredients. Thus, leading companies have been focusing on developing new and sustainable ways of producing the ingredi...
Post a Comment
Read more

High-End Synthetic Suede Market Latest Trend, Industry Growth, Competitive Analysis Upto 2031

High-end synthetic suede has been able to mark its presence in the fashion industry as well. Global fashion designers, with an aim to inculcate sustainability, have started to incorporate synthetic materials in their production process, to not only achieve sustainability but also to send a strong message to their customers regarding the proliferated use of vegan materials. The growth in the high-end synthetic suede market is attributable to increasing demand from the automotive industry and the need for a replacement of natural suede. Synthetic suede is made through the blends of polyester and other plastics, posing less environmental hazard just like natural suede does. Synthetic suede is typically more economical and affordable as compared to natural suede. The material is highly durable and requires low maintenance, which has made it a popular choice as a replacement of natural suede. The increase in the number of end-use industries, rise in the demand for a replacement of natural s...
Post a Comment
Read more

Liquid Biopsy, North America, and Lung Cancer Occupying a Major Share in the Market

  Owing to the market availability of large number of liquid biopsy technologies, the liquid biopsy segment currently accounts for a dominating share in the global minimally invasive biopsy technologies market . However, the market growth in the segment can be attributed to the increasing demand for liquid biopsy and the strong product pipeline. For instance, CNI Second Opinion by Chronix Biomedical is presently under development and is expected to get launched during the forecast period 2019-2030. Owing to a widespread market presence of leading players and the huge prevalence of cancer, North America presently holds a major share in the global minimally invasive biopsy technologies market. According to the World Cancer Research Fund (WCRF), with an estimated 2 million cases in 2018, lung cancer is the most commonly occurring cancer in men and third-most commonly occurring cancer in women. Due to the widespread presence of cancer, the manufacturers including Biocept, Inc., Chron...
Post a Comment
Read more